Statistics

Total Visits

Views
Gemcitabine and Capecitabine as Third- or Later-line Therapy for Refractory Advanced Colorectal Cancer: A Retrospective Study121

Select a period of time:

Number of views in the range

Views
Gemcitabine and Capecitabine as Third- or Later-line Therapy for Refractory Advanced Colorectal Cancer: A Retrospective Study33

Views

Views
December 20256
January 20260
February 20260
March 20264
April 202612
May 20264
June 20267
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States13
Netherlands5
United Kingdom2
Germany2
Angola1
Austria1
Brazil1
China1
Egypt1
France1
 

Top cities views

Views
Groningen5
Frankfurt am Main2
Atlanta1
Belo Oriente1
Bilecik1
Bolingbrook1
Cairo1
Detroit1
Lima1
Los Angeles1